Table 2.
Final diagnoses in 28 patients with negative RASopathy next-generation sequencing test results
Final diagnosis |
---|
Cytogenetic disorders |
Unbalanced translocation: 46,XY,der(9)t(2;9)(q34;p23) |
7.01 Mb terminal deletion on chromosome 11q24.3q25, Jacobsen syndrome |
4.23 Mb deletion of 4p16.3, Wolff-Hirschhorn syndrome |
2.73 Mb duplication of 1q21.1q21.2 |
1.74 Mb duplication of 1q21.3q22 |
22q11.2 duplication (A to D region) |
313 kb deletion of 8q24.3 |
411 kb duplication of 16q24.1 |
1.92 Mb duplication of 15q26.1 |
62.9 Mb maternal uniparental isodisomy 20p13q13.33 |
Single-gene disorders |
IFT122 p.A446V homo, cranioectodermal dysplasia type I |
ARID1B p.G351AfsX12 het, Coffin-Siris syndrome |
MRPS22 p.R170H; p.G257KfsX3 comp het, combined oxidative phosphorylation deficiency 5 |
GHR p.R179C het, paternally inherited, GHR |
FERMT3 p.R573* homo, leukocyte adhesion deficiency |
SLC25A3 p.L200W, p.G296_S300delinsQIF compound het, mitochondrial phosphate carrier deficiency |
NF1 p.K1423G het, neurofibromatosis with Noonan syndrome–like features |
FZD6 p.R116* and p.C461R compound het, disease-candidate gene |
IDUA p.Q70* homo, mucopolysaccharidosis type I |
NEBL p.S539* het, dilated cardiomyopathy |
PEX12 c.888_889del CT and c.894delC compound het, peroxisome biogenesis disorder 3A (Zellweger) |
RBM10 p.M415L hemi, de novo TARP syndrome |
BZRAP1 p.R1375* and p.R215G compound het, disease-candidate gene |
KMT2A p.S2110* het, de novo Wiedemann–Steiner syndrome |
Clinically diagnosed syndromes |
Beckwith–Wiedemann syndrome and probably an additional undiagnosed syndrome |
Ehlers–Danlos syndrome |
Segmental neurofibromatosis type I |
Jeune syndrome |
Neurofibromatosis type I was found in two patients; all other diagnoses found were in one patient each.
TARP syndrome: talipes equinovarus, atrial septal defect, Robin sequence, and persistence of the left superior vena cava.